Inj, labetalol hcl, 5mg
Products billed under this code include Labetalol HCl.
Payment limit per 5 MG, by effective quarter, 3Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Labetalol HCl.
Payment limit per 5 MG, by effective quarter, 3Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Labetalol HCl | Hikma Pharmaceuticals USA Inc. | 00143-9320-01 | 20 | $11.76 |
| Labetalol HCl | Hikma Pharmaceuticals USA Inc. | 00143-9622-01 | 20 | $11.76 |
| Labetalol HCl | Hikma Pharmaceuticals USA Inc. | 00143-9623-01 | 40 | $23.52 |
| Labetalol HCl | Pfizer Inc | 00409-0125-25 | 500 | $294.00 |
| Labetalol HCl | Pfizer Inc | 00409-2267-54 | 40 | $23.52 |
| Labetalol HCl | Pfizer Inc | 00409-2339-34 | 40 | $23.52 |
| Labetalol HCl | Sagent Pharmaceuticals | 25021-0317-20 | 20 | $11.76 |
| Labetalol HCl | Sagent Pharmaceuticals | 25021-0317-40 | 40 | $23.52 |
| Labetalol HCl | Baxter Healthcare Corporation | 36000-0320-10 | 40 | $23.52 |
| Labetalol HCl | Baxter Healthcare Corporation | 36000-0322-02 | 20 | $11.76 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Labetalol HCl | Baxter Healthcare Corporation | 36000-0324-02 | 40 | $23.52 |
| Labetalol HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1228-01 | 20 | $11.76 |
| Labetalol HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1602-01 | 20 | $11.76 |
| Labetalol HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1602-09 | 20 | $11.76 |
| Labetalol HCl | Caplin Steriles USA Inc. | 65145-0124-01 | 20 | $11.76 |
| Labetalol HCl | Caplin Steriles USA Inc. | 65145-0125-01 | 40 | $23.52 |
| Labetalol HCl | Amneal Pharmaceuticals, LLC | 70121-2428-03 | 96 | $56.448 |
| Labetalol HCl | Fosun Pharma USA Inc. | 72266-0102-01 | 20 | $11.76 |
| Labetalol HCl | Fosun Pharma USA Inc. | 72266-0103-01 | 40 | $23.52 |
| Labetalol HCl | Fosun Pharma USA Inc. | 72266-0103-41 | 40 | $23.52 |
| Labetalol HCl | Civica, Inc. | 72572-0350-01 | 20 | $11.76 |
| Labetalol HCl | Northstar RxLLC | 72603-0146-01 | 20 | $11.76 |
| Labetalol HCl | Mullan Pharmaceutical Inc. | 83301-0059-01 | 40 | $23.52 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.588 | +$0.37 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted September 17, 2026 |
| 3Q26 | $0.218 | −$0.039 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted September 15, 2026 |
| 2Q26 | $0.257 | −$0.091 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted September 15, 2026 |
| 1Q26 | $0.348 | +$0.006 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted September 15, 2026 |
| 4Q25 | $0.342 | −$0.047 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted September 8, 2026 |
| 3Q25 | $0.389 | −$0.03 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted March 10, 2026 |
| 2Q25 | $0.419 | +$0.125 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted March 10, 2026 |
| 1Q25 | $0.294 | +$0.027 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted December 19, 2025 |
| 4Q24 | $0.267 | +$0.093 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted June 11, 2025 |
| 3Q24 | $0.174 | +$0.009 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted June 11, 2025 |
| 2Q24 | $0.165 | −$0.021 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted March 11, 2025 |
| 1Q24 | $0.186 | +$0.003 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted December 19, 2024 |
| 4Q23 | $0.183 | −$0.061 | 5 MG | Inj, labetalol hcl, 5mg | v1, posted October 10, 2024 |
| 3Q23 | $0.244 | – | 5 MG | Inj, labetalol hcl, 5mg | v1, posted June 5, 2024 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.